Technology Our technology is based upon patented hydrogels, comprising 97.5% water and 2.5% cross-linked polyacrylamide. Once injected, the homogenous, biocompatible, viscoelastic hydrogel maintains its volume by continually exchanging water with the surrounding host tissues. They are permeable to salts and organic molecules, allowing cells to integrate through the gel after injection. 3 months Partially integrated 1 year Fully integrated 2.5 years Fully integrated Our hydrogels are non-particulate so do not contain a carrier gel, making them non-absorbable, non-migratory and highly durable. Unlike many particulate gels, they do not rely on a response from the host tissue to generate their desired effect through a chronic inflammation but rather act through the volume of hydrogel itself integrated with a fine vessel bearing fibrous network . As a result, they do not suffer from the inherent issues of particulate based gels, namely an unpredictable desired effect, particle migration or tissue hardening. Aquamid and Arthrosamid are registered trademarks of Contura International A/S. Contura Vet is a registered trademark of Contura Vet Ltd. Cystistat is a registered Trademark of Mylan Institutional Ltd. Privacy Notice © copyright 2021 Contura International Ltd.

Aquamid is a non-absorbable hydrogel for soft tissue augmentation. Aquamid is a non-absorbable high viscoelastic hydrogel for soft tissue augmentation. Aquamid has been successfully used in patients with facial lipoatrophy, amongst others, and its safety and efficacy data show excellent results over a period of more than 10 years. GO TO WEBSITE CLINICAL DATA IFU Aquamid and Arthrosamid are registered trademarks of Contura International A/S. Contura Vet is a registered trademark of Contura Vet Ltd. Cystistat is a registered Trademark of Mylan Institutional Ltd. Privacy Notice © copyright 2021 Contura International Ltd.